VentriPoint Diagnostics Ltd.
VPT.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.21% | 24.19% | 16.75% | -4.77% | -24.95% |
| Total Depreciation and Amortization | -4.35% | -12.50% | -9.84% | -7.32% | -7.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 307.46% | 270.04% | -86.38% | 366.19% | -10.96% |
| Change in Net Operating Assets | 32.04% | 53.78% | 160.19% | -152.36% | 611.98% |
| Cash from Operations | 50.83% | 66.37% | 29.37% | 29.96% | -14.34% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -91.11% | -- | -- | -- | -- |
| Total Debt Repaid | -3.06% | 56.34% | 0.00% | -10.11% | 8.41% |
| Issuance of Common Stock | -- | 19.41% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -60.54% | 1,883.47% | 2,438.89% | 1,900.00% | 3,268.62% |
| Foreign Exchange rate Adjustments | 741.18% | 103.77% | -393.26% | 178.08% | -137.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.13% | 129.84% | 95.17% | 80.96% | 92.94% |